CEO David Hung was paid $3,876,736 in fiscal year 2025, ↑ up 4.3% from fiscal year 2024 (SEC filing 0001140361-26-014157 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$3,876,736 ↑ David Hung total, FY2025 | — CEO pay percentile vs peers | — CEO-to-median pay ratio | 97.89% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
NUVB's next annual pay disclosure, estimated April 12, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| David Hung | $650,016 | $0 | $0 | $2,674,636 | $536,250 | $0 | $15,834 | $3,876,736 |
| President and Chief Executive Officer | ||||||||
| Philippe Sauvage | 510,000 | — | 0 | 668,659 | 252,450 | 0 | 47,568 | 1,478,677 |
| Chief Financial Officer | ||||||||
| Gary Hattersley | 515,072 | 668,659 | 0 | 254,925 | 35,806 | 0 | 0 | 1,472,462 |
| Chief Scientific Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| David Hung | $3,876,736 | $3,717,354 | — | ↑ +159,382 |
| Philippe Sauvage | 1,478,677 | 1,190,956 | — | ↑ +287,721 |
| Gary Hattersley | 1,472,462 | 1,406,750 | — | ↑ +65,712 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Nuvation Bio's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper NUVB reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
Each company listed discloses NUVB in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named NUVB in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Kathryn E. Falberg | Independent Director | $445,000 |
| Kim Blickenstaff | Independent Director | $436,250 |
| Min Cui, Ph.D | Independent Director | — |
| Robert B. Bazemore Jr | Independent Director | $483,000 |
| Robert Mashal, M.D | Independent Director | $422,500 |
| W. Anthony Vernon | Independent Director | $446,000 |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 2026-04-17 | A | 36,750 | $3 | $107,678 | Common | Form 4 ↗ |
| Dongfang Liu | CHIEF MEDICAL OFFICER | 2026-04-17 | D | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dongfang Liu | CHIEF MEDICAL OFFICER | 2026-04-17 | D | 50,000 | 5 | 251,000 | Common | Form 4 ↗ |
| Dongfang Liu | CHIEF MEDICAL OFFICER | 2026-04-17 | A | 50,000 | 2 | 97,000 | Common | Form 4 ↗ |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 2026-04-17 | D | 36,750 | 5 | 184,279 | Common | Form 4 ↗ |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 2026-04-17 | D | 36,750 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Xiangmin Cui | Director | 2026-05-21 | A | 123,397 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Robert B. Bazemore Jr | Director | 2026-05-21 | A | 123,397 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kim Blickenstaff | Director | 2026-05-21 | A | 123,397 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kathryn E. Falberg | Director | 2026-05-21 | A | 123,397 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Robert Mashal | Director | 2026-05-21 | A | 123,397 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| W. Anthony Vernon | Director | 2026-05-21 | A | 123,397 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Robert Mashal | Director | 2026-06-09 | A | 25,000 | 5 | 118,250 | Common | Form 4 ↗ |
| Philippe Sauvage | Chief Financial Officer | 2026-06-23 | D | 47,668 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Philippe Sauvage | Chief Financial Officer | 2026-06-23 | D | 47,668 | 6 | 286,370 | Common | Form 4 ↗ |
| Philippe Sauvage | Chief Financial Officer | 2026-06-23 | A | 47,668 | 2 | 103,440 | Common | Form 4 ↗ |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 2026-06-23 | D | 63,000 | 6 | 379,191 | Common | Form 4 ↗ |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 2026-06-23 | A | 63,000 | 3 | 184,590 | Common | Form 4 ↗ |
| Stacy Markel | CHIEF PEOPLE OFFICER | 2026-06-23 | D | 34,620 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Stacy Markel | CHIEF PEOPLE OFFICER | 2026-06-23 | D | 90,380 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Stacy Markel | CHIEF PEOPLE OFFICER | 2026-06-23 | D | 125,000 | 6 | 753,188 | Common | Form 4 ↗ |
| Stacy Markel | CHIEF PEOPLE OFFICER | 2026-06-23 | A | 34,620 | 2 | 60,239 | Common | Form 4 ↗ |
| Stacy Markel | CHIEF PEOPLE OFFICER | 2026-06-23 | A | 90,380 | 2 | 169,011 | Common | Form 4 ↗ |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 2026-06-23 | D | 63,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-07-15 | — | 1 | — | — | 1 insider, 1 accrual row | ||
| Philippe Sauvage | Chief Financial Officer | 2026-07-15 | A | 39,999 | 2 | 86,798 | Common | Form 4 ↗ |
| Philippe Sauvage | Chief Financial Officer | 2026-07-15 | D | 39,999 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Philippe Sauvage | Chief Financial Officer | 2026-07-15 | A | 1 | 2 | 2 | Common | Form 4 ↗ |
| Gary Hattersley | CHIEF SCIENTIFIC OFFICER | 2026-08-19 | D | 100,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Gary Hattersley | CHIEF SCIENTIFIC OFFICER | 2026-08-19 | D | 100,000 | 7 | 709,240 | Common | Form 4 ↗ |
| Gary Hattersley | CHIEF SCIENTIFIC OFFICER | 2026-08-19 | A | 100,000 | 2 | 187,000 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 2026-04-17 | A | 36,750 | $3 | $107,678 | Common | Form 4 ↗ |
| Dongfang Liu | CHIEF MEDICAL OFFICER | 2026-04-17 | D | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dongfang Liu | CHIEF MEDICAL OFFICER | 2026-04-17 | D | 50,000 | 5 | 251,000 | Common | Form 4 ↗ |
| Dongfang Liu | CHIEF MEDICAL OFFICER | 2026-04-17 | A | 50,000 | 2 | 97,000 | Common | Form 4 ↗ |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 2026-04-17 | D | 36,750 | 5 | 184,279 | Common | Form 4 ↗ |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 2026-04-17 | D | 36,750 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Xiangmin Cui | Director | 2026-05-21 | A | 123,397 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Robert B. Bazemore Jr | Director | 2026-05-21 | A | 123,397 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kim Blickenstaff | Director | 2026-05-21 | A | 123,397 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kathryn E. Falberg | Director | 2026-05-21 | A | 123,397 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Robert Mashal | Director | 2026-05-21 | A | 123,397 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| W. Anthony Vernon | Director | 2026-05-21 | A | 123,397 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Robert Mashal | Director | 2026-06-09 | A | 25,000 | 5 | 118,250 | Common | Form 4 ↗ |
| Philippe Sauvage | Chief Financial Officer | 2026-06-23 | D | 47,668 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Philippe Sauvage | Chief Financial Officer | 2026-06-23 | D | 47,668 | 6 | 286,370 | Common | Form 4 ↗ |
| Philippe Sauvage | Chief Financial Officer | 2026-06-23 | A | 47,668 | 2 | 103,440 | Common | Form 4 ↗ |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 2026-06-23 | D | 63,000 | 6 | 379,191 | Common | Form 4 ↗ |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 2026-06-23 | A | 63,000 | 3 | 184,590 | Common | Form 4 ↗ |
| Stacy Markel | CHIEF PEOPLE OFFICER | 2026-06-23 | D | 34,620 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Stacy Markel | CHIEF PEOPLE OFFICER | 2026-06-23 | D | 90,380 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Stacy Markel | CHIEF PEOPLE OFFICER | 2026-06-23 | D | 125,000 | 6 | 753,188 | Common | Form 4 ↗ |
| Stacy Markel | CHIEF PEOPLE OFFICER | 2026-06-23 | A | 34,620 | 2 | 60,239 | Common | Form 4 ↗ |
| Stacy Markel | CHIEF PEOPLE OFFICER | 2026-06-23 | A | 90,380 | 2 | 169,011 | Common | Form 4 ↗ |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 2026-06-23 | D | 63,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Philippe Sauvage | Chief Financial Officer | 2026-07-15 | D | 1 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Philippe Sauvage | Chief Financial Officer | 2026-07-15 | A | 39,999 | 2 | 86,798 | Common | Form 4 ↗ |
| Philippe Sauvage | Chief Financial Officer | 2026-07-15 | D | 39,999 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Philippe Sauvage | Chief Financial Officer | 2026-07-15 | A | 1 | 2 | 2 | Common | Form 4 ↗ |
| Gary Hattersley | CHIEF SCIENTIFIC OFFICER | 2026-08-19 | D | 100,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Gary Hattersley | CHIEF SCIENTIFIC OFFICER | 2026-08-19 | D | 100,000 | 7 | 709,240 | Common | Form 4 ↗ |
| Gary Hattersley | CHIEF SCIENTIFIC OFFICER | 2026-08-19 | A | 100,000 | 2 | 187,000 | Common | Form 4 ↗ |
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Colleen Sjogren | OPTION | 2025-02-28 | — | — | 88 | — | $448,182 |
| David Hung | OPTION | 2025-02-28 | — | — | 88 | — | 2,000,000 |
| Gary Hattersley | OPTION | 2025-02-28 | — | — | 88 | — | 448,182 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Colleen Sjogren | $0 | $0 | $448,182 | 0.0% |
| David Hung | 0 | 0 | 2,000,000 | 0.0% |
| Gary Hattersley | 0 | 0 | 448,182 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Gary Hattersley | Option | 500,000 | 1.97 | — |
| David Hung | Option | 83,334 | 5.06 | — |
| Philippe Sauvage | Option | 531,250 | 2.17 | — |
| David Hung | Option | 1,086,334 | 1.87 | — |
| David Hung | Option | 134,856 | 12.66 | — |
| David Hung | Option | 729,167 | 1.94 | — |
| David Hung | Option | 2,000,000 | 1.97 | — |
| Philippe Sauvage | Option | 500,000 | 1.97 | — |
| Gary Hattersley | Option | 20,834 | 5.06 | — |
| Gary Hattersley | Option | 66,667 | 2.93 | — |
| Gary Hattersley | Option | 145,834 | 1.94 | — |
| Gary Hattersley | Option | 270,834 | 1.87 | — |
The Company's compensation program is designed to attract and retain talented executives, reward performance, and align executive interests with stockholders through equity incentives.
| CEO STI target (% of salary) | 75% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | FW Cook |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-21 | 230,050,644 | 4,950,024 | 328,694 | 97.89% | Passed |
| 2025 | 2025-05-21 | 214,903,033 | 1,601,869 | 143,821 | 99.26% | Passed |
| 2024 | 2024-09-03 | 208,479,505 | 1,832,719 | 568,555 | 99.13% | Passed |
| 2023 | 2023-05-15 | 153,714,329 | 38,025,124 | 9,887 | 80.17% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-05-21 | 97.89%a |
| 2025 | 2025-05-21 | 99.26%b |
| 2024 | 2024-09-03 | 99.13%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on the outcome of the vote;”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Robert B. Bazemore JrIndependent · Audit · Compensation · Nominating and Corporate Governance (Chair) | $98,000 | $0 | $385,000 | — | $0 | $483,000 |
| W. Anthony VernonIndependent · Compensation (Chair) · Nominating and Corporate Governance | 61,000 | 0 | 385,000 | — | 0 | 446,000 |
| Kathryn E. FalbergIndependent · Audit (Chair) | 60,000 | 0 | 385,000 | — | 0 | 445,000 |
| Kim BlickenstaffIndependent · Audit · Compensation | 51,250 | 0 | 385,000 | — | 0 | 436,250 |
| Robert Mashal, M.DIndependent · Nominating and Corporate Governance | 37,500 | 0 | 385,000 | — | 0 | 422,500 |
| David Hung, M.DEmployee director | — | — | — | — | — | 0 |
| Min Cui, Ph.DIndependent · Compensation · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 12,000 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $307,750 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $307,750 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Nuvation Bio | 2025 | David Hung | $650,016 | $0 | $2,674,636 | $536,250 | $3,876,736 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, David Hung | DEF 14A | 2026-04-10 | 0001140361-26-014157 | Section “Executive Compensation”. As printed: 3,876,736. Filing ↗machine: r2 · c21 · span 357088–357098 |
| 2 | Section 01, Philippe Sauvage | DEF 14A | 2026-04-10 | 0001140361-26-014157 | Section “Executive Compensation”. As printed: 1,478,677. Filing ↗machine: r4 · c21 · span 364911–364921 |
| 3 | Section 01, Gary Hattersley | DEF 14A | 2026-04-10 | 0001140361-26-014157 | Section “Executive Compensation”. As printed: 1,472,462. Filing ↗ |
| 4 | Section 03, Colleen Sjogren OPTION | DEF 14A | 2026-04-10 | 0001140361-26-014157 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t115 · r3 · c6 · span 646651–646658 |
| 5 | Section 03, David Hung OPTION | DEF 14A | 2026-04-10 | 0001140361-26-014157 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t89 · r8 · c10 · span 422293–422302 |
| 6 | Section 03, Gary Hattersley OPTION | DEF 14A | 2026-04-10 | 0001140361-26-014157 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t115 · r4 · c6 · span 650260–650267 |
| 7 | Section 07, pay ratio | 10-K | 2026-03-02 | 0001193125-26-085584 | Section “CEO Pay Ratio”. As printed: —. Filing ↗ |
| 8 | Section 08, Robert B. Bazemore Jr | DEF 14A | 2026-04-10 | 0001140361-26-014157 | Section “Director Compensation”. As printed: 483,000. Filing ↗machine: span 271896–272076 |
| 9 | Section 08, W. Anthony Vernon | DEF 14A | 2026-04-10 | 0001140361-26-014157 | Section “Director Compensation”. As printed: 446,000. Filing ↗machine: span 281125–281304 |
| 10 | Section 08, Kathryn E. Falberg | DEF 14A | 2026-04-10 | 0001140361-26-014157 | Section “Director Compensation”. As printed: 445,000. Filing ↗machine: span 277491–277671 |
| 11 | Section 08, Kim Blickenstaff | DEF 14A | 2026-04-10 | 0001140361-26-014157 | Section “Director Compensation”. As printed: 436,250. Filing ↗machine: span 273624–273804 |
| 12 | Section 08, Robert Mashal, M.D | DEF 14A | 2026-04-10 | 0001140361-26-014157 | Section “Director Compensation”. As printed: 422,500. Filing ↗machine: span 279492–279672 |
| 13 | Section 08, David Hung, M.D | DEF 14A | 2026-04-10 | 0001140361-26-014157 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 14 | Section 08, Min Cui, Ph.D | DEF 14A | 2026-04-10 | 0001140361-26-014157 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 15 | Section 02, Kerry Wentworth 2026-04-17 | Form 4 | 2026-04-21 | 0001369453-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 16 | Section 02, Dongfang Liu 2026-04-17 | Form 4 | 2026-04-21 | 0001937915-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 17 | Section 02, Dongfang Liu 2026-04-17 | Form 4 | 2026-04-21 | 0001937915-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 18 | Section 02, Dongfang Liu 2026-04-17 | Form 4 | 2026-04-21 | 0001937915-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 19 | Section 02, Kerry Wentworth 2026-04-17 | Form 4 | 2026-04-21 | 0001369453-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 20 | Section 02, Kerry Wentworth 2026-04-17 | Form 4 | 2026-04-21 | 0001369453-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 21 | Section 02, Xiangmin Cui 2026-05-21 | Form 4 | 2026-05-26 | 0001487815-26-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 22 | Section 02, Robert B. Bazemore Jr 2026-05-21 | Form 4 | 2026-05-26 | 0001620152-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 23 | Section 02, Kim Blickenstaff 2026-05-21 | Form 4 | 2026-05-26 | 0001238913-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 24 | Section 02, Kathryn E. Falberg 2026-05-21 | Form 4 | 2026-05-26 | 0001206977-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, Robert Mashal 2026-05-21 | Form 4 | 2026-05-26 | 0002007102-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, W. Anthony Vernon 2026-05-21 | Form 4 | 2026-05-26 | 0001369091-26-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Robert Mashal 2026-06-09 | Form 4 | 2026-06-11 | 0002007102-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, Philippe Sauvage 2026-06-23 | Form 4 | 2026-06-24 | 0002039891-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, Philippe Sauvage 2026-06-23 | Form 4 | 2026-06-24 | 0002039891-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Philippe Sauvage 2026-06-23 | Form 4 | 2026-06-24 | 0002039891-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, Kerry Wentworth 2026-06-23 | Form 4 | 2026-06-24 | 0001369453-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Kerry Wentworth 2026-06-23 | Form 4 | 2026-06-24 | 0001369453-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Stacy Markel 2026-06-23 | Form 4 | 2026-06-24 | 0001734780-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Stacy Markel 2026-06-23 | Form 4 | 2026-06-24 | 0001734780-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Stacy Markel 2026-06-23 | Form 4 | 2026-06-24 | 0001734780-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Stacy Markel 2026-06-23 | Form 4 | 2026-06-24 | 0001734780-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Stacy Markel 2026-06-23 | Form 4 | 2026-06-24 | 0001734780-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Kerry Wentworth 2026-06-23 | Form 4 | 2026-06-24 | 0001369453-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Philippe Sauvage 2026-07-15 | Form 4 | 2026-07-17 | 0002039891-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Philippe Sauvage 2026-07-15 | Form 4 | 2026-07-17 | 0002039891-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Philippe Sauvage 2026-07-15 | Form 4 | 2026-07-17 | 0002039891-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Philippe Sauvage 2026-07-15 | Form 4 | 2026-07-17 | 0002039891-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Gary Hattersley 2026-08-19 | Form 4 | 2026-08-21 | 0001521111-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Gary Hattersley 2026-08-19 | Form 4 | 2026-08-21 | 0001521111-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Gary Hattersley 2026-08-19 | Form 4 | 2026-08-21 | 0001521111-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 06, 2026 vote | Form 8-K | 2026-05-27 | 0001193125-26-241922 | Item 5.07 · say-on-pay result. As reported: 97.89% (votes for as printed: 230,050,644). Filing ↗ |
| 47 | Section 06, 2025 vote | Form 8-K | 2025-05-23 | 0001193125-25-125763 | Item 5.07 · say-on-pay result. As reported: 99.26% (votes for as printed: 214,903,033). Filing ↗ |
| 48 | Section 06, 2024 vote | Form 8-K | 2024-09-05 | 0001193125-24-214241 | Item 5.07 · say-on-pay result. As reported: 99.13% (votes for as printed: 208,479,505). Filing ↗ |
| 49 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 50 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 51 | Section 09b board cost (computed) | Computed | — | — | Cash 307,750 + equity 0 + all other 0 = 307,750, summed across the director compensation table rows.machine: formula: Σ = 307,750 |
| 52 | Nuvation Bio (subject), Section 10b CEO total | DEF 14A | 2026-04-10 | 0001140361-26-014157 | CEO total compensation as printed in Nuvation Bio's own proxy. As printed: 3,876,736. Filing ↗machine: r2 · c21 · span 357088–357098 |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.